DOI:
10.1055/s-00029029
Journal of Pediatric Intensive Care
LinksClose Window
References
Mahat U, Matar RB, Rotz SJ.
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
Pediatr Blood Cancer 2019;
66 (11) e27913
We do not assume any responsibility for the contents of the web pages of other providers.